about
Simple, distance-based measurement for paper analytical devicesGSTT2 promoter polymorphisms and colorectal cancer riskThe Prodrug Approach: A Successful Tool for Improving Drug SolubilityAntibody-drug conjugates as novel anti-cancer chemotherapeuticsExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesExpanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysChemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarizationKRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor TreatmentMetabolic consequences of oncogenic IDH mutationsDual Regulation of Cell Death and Cell Survival upon Induction of Cellular Stress by Isopimara-7,15-Dien-19-Oic Acid in Cervical Cancer, HeLa Cells In vitroHeterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxiaTraceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivoSmart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersOxidative stress, inflammation, and cancer: how are they linked?Stimuli-Responsive Materials for Controlled Release of Theranostic Agents.Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levelsDoxorubicin-loaded aromatic imine-contained amphiphilic branched star polymer micelles: synthesis, self-assembly, and drug delivery.Magnetic Resonance (MR) Metabolic Imaging in Glioma.A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung AdenocarcinomaBioreducible cross-linked core polymer micelles enhance in vitro activity of methotrexate in breast cancer cells.Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity.Multi-stimuli sensitive amphiphilic block copolymer assembliesTumor grade related expression of neuroglobin is negatively regulated by PPARĪ³ and confers antioxidant activity in glioma progressionTumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism.Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysisLiquid Chromatography Mass Spectrometry-Based Metabolite Pathway Analyses of Myeloma and Non-Hodgkin's Lymphoma PatientsMicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells.Trigger-Responsive Gene Transporters for Anticancer Therapy.Photo and redox dual responsive reversibly cross-linked nanocarrier for efficient tumor-targeted drug deliveryPEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.A metabolic study on colon cancer using (1)h nuclear magnetic resonance spectroscopy.Comparison of low and high dose ionising radiation using topological analysis of gene coexpression networks.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionCellular redox imbalance and changes of protein S-glutathionylation patterns are associated with senescence induced by oncogenic H-rasSulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activation.Association of selenium status and blood glutathione concentrations in blacks and whites
P2860
Q23911802-B8CAB0F5-E397-4EAF-B0F2-DAA979554868Q24677878-14452E45-B0BF-4204-BD9C-16F6DE9FA03BQ26771271-14C3B4C9-D41E-42BF-BCBC-AE8651DC00A6Q26800175-A93A8EF7-C75E-4931-8B70-B9BEE765DCC2Q26828930-09E12BEE-8EE5-44CA-827F-EBDA840FFF3EQ26861539-91B6AFF4-DEF4-4743-999F-8D6131276BF0Q27023363-99F65DEB-30B7-4F9C-BEEE-622238981487Q27853300-BD5AE246-4300-465A-B08C-717010D465C8Q28078974-C51DB981-8CEC-4499-97CE-FCC0DEBA20B8Q28082949-5195AFD4-4787-410B-B70A-88039B4A83EEQ28390946-343C4878-0D1E-4043-92E1-51697D509EE1Q28478325-185910B2-69EB-4BEC-BD37-A76069302446Q28539158-ECA67380-A665-41C6-BBFC-84711EA2D0BDQ28817755-F7DC30F4-E79B-493E-89DA-9724267D27CAQ29616835-9AD3ABAD-F6CC-4026-8BF9-7D0AF21C6DFEQ30406730-A1FF54D5-2104-451F-81BD-9C275E492870Q30831591-696F56D0-D863-4320-B7C3-3E3F69FF3B0FQ30968289-3E61D4D8-03DE-4AB8-8064-D9B728904A5EQ31015256-13717D9C-030A-4F0C-B0CB-D04180301EB7Q31018336-BCDDD058-2211-4FF2-A7BB-401B331F2C0FQ32182725-C270AB51-0F81-497F-8275-F7D411D34384Q33378907-A5A2D2D9-4E3A-4917-907B-9DC3C2F2AAF6Q33418690-60C8042B-F7A9-4E8D-9587-296A99CB893EQ33561578-64FBA39C-3204-424B-8BE6-171AAB94CE76Q33565555-183E0A7F-7B02-40C8-855E-4006EE52DD2BQ33626165-5D8CD439-CC6C-4613-8981-DEE0DC7816BDQ33690907-366DF5A5-C81F-40AA-ABA2-FD114A3F61ABQ33697415-6223157F-7FDC-483B-80AE-E23B30A49300Q33738082-216788A3-3BE7-45DD-88A1-C4C90090267FQ33808084-F97FA32C-B45C-42FE-9934-3964F3568E08Q33837834-BAAF4F36-F334-4E8F-836C-7F04A266E9C2Q33889055-054F9DFA-7860-4C79-8871-228DCB70D447Q34069847-96C2431B-E7B2-466F-B061-82E3DCB991EFQ34114008-C8F055A8-2EA5-4281-AC9A-B2B1844783B8Q34272329-C94EC687-263C-4165-AC48-975A1CCA8C14Q34459681-F9E778EC-90BF-4B9D-A457-4DD87D90390BQ34533152-289EB993-08AB-4785-AB2A-3DA7529ED0D2Q34543666-A32E1ECB-C642-4E19-B537-9DBBAD7ABBD8Q34598991-D2963E3E-81A8-470E-9F7E-72F01712399BQ34925063-FA440C21-B8AE-4D10-A524-17613422B1AC
P2860
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2004 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¶ÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
name
The role of glutathione in cancer.
@ast
The role of glutathione in cancer.
@en
The role of glutathione in cancer.
@nl
type
label
The role of glutathione in cancer.
@ast
The role of glutathione in cancer.
@en
The role of glutathione in cancer.
@nl
prefLabel
The role of glutathione in cancer.
@ast
The role of glutathione in cancer.
@en
The role of glutathione in cancer.
@nl
P356
P1476
The role of glutathione in cancer
@en
P2093
Deborah Fraser
Ganesaratnam K Balendiran
P304
P356
10.1002/CBF.1149
P50
P577
2004-11-01T00:00:00Z